CARTHERA

Description

CARTHERA develops SonoCloud, an implanted ultrasound device that emits low-intensity pulsed ultrasound to transiently open the blood–brain barrier and increase brain delivery of chemotherapies and other therapeutic agents for severe brain disorders.

Related

• BioArcticBioArctic develops therapeutics and related technologies for neurodegenerative disorders, focusing on disease-modifying treatments and…
• Gate2BrainGate2Brain produces a peptide-based, patented technology platform of three peptide-shuttle families that improve delivery and…
• ceregateceregate provides a hardware-agnostic computer–brain interface platform that enables new communication channels with the brain to restore…
• RobeautéRobeauté develops a brain microrobotic platform for neuro-interventions, using rice-sized microrobots and related infrastructure to better…
• OrganoTherapeuticsOrganoTherapeutics creates human iPSC-derived midbrain organoids, assembloids, and patient-specific Parkinson’s cell models, then provides…
• inbrain-neuroelectronicsinbrain-neuroelectronics develops a graphene-based brain–computer interface that detects high-frequency neural activity with…
• NTrans TechnologiesNTrans Technologies develops a non-viral delivery platform for cell and gene therapies, providing modular delivery solutions for…
• Anacalypsis TherapeuticsAnacalypsis Therapeutics creates precision gene- and pathway-based therapeutic strategies, biomarkers, and genetically linked targets to…
• Aurora Cold Plasma SterilisationAurora Cold Plasma Sterilisation makes medical-device sterilizers that use cold plasma as the sterilizing agent and supplies compatible…